Nanomaterial Complexes Enriched With Natural Compounds Used in Cancer Therapies: A Perspective for Clinical Application
Review
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Resveratrol and quercetin are natural compounds contained in many foods and beverages. Reports indicate implications for the health of the general population; on the other hand the use of both compounds has interesting results for the treatment of many diseases as cardiovascular affections, diabetes, Alzheimer’s disease, viral and bacterial infections among others. Based on their capacities described as anti-inflammatory, antioxidant, and anti-aging, resveratrol and quercetin showed antiproliferative and anticancer activity specifically in maligned cells. These molecular characteristics trigger the pharmacological repurposing of both compounds and improved its research for treating different cancer types with interesting results at in vitro, in vivo, and clinical trial studies. Meanwhile, the development of different systems of drug release in specific sites as nanomaterials and specifically the nanoparticles, potentiates the personal treatment perspective in conjunct with the actual cancer therapies; regularly invasive and aggressive, the perspective of nanomedicine as higher effective and lower invasive has gained popularity. Knowledge of molecular interactions of resveratrol and quercetin in diseases confirms the evidence of multiple benefits, while the multiple analyses suggested a positive response for the treatment and diagnostics of cancer in different stages, including at metastatic stage. The present work reviews the reports related to the impact of resveratrol and quercetin in cancer treatment and its effects when the antioxidants are encapsulated in different nanoparticle systems, which improve the prospects of cancer treatment. © Copyright © 2021 Saavedra-Leos, Jordan-Alejandre, López-Camarillo, Pozos-Guillen, Leyva-Porras and Silva-Cázares.
publication date
published in
Research
keywords
-
cancer; nanomaterials; pharmacological repurposing; quercetin; resveratrol acetylsalicylic acid; advanced glycation end product receptor; alantolactone; androstanolone; antioxidant; arsenic trioxide; arsenite sodium; caspase 3; chitosan; curcumin; cyclophosphamide; docetaxel; doxorubicin; ellagic acid; epirubicin; flavonoid; folic acid; galectin 3; hyaluronic acid; hydrogel; hydroxymethylglutaryl coenzyme A reductase inhibitor; liposome; matrilysin; microsphere; mitogen activated protein kinase p38; nanocrystal; nanomaterial; nanoparticle; natural product; paclitaxel; pheophorbide; polypyrrole; prostate specific antigen; protein p53; quercetin; resistin; resveratrol; sirtuin 1; small interfering RNA; tamoxifen; testosterone; vasculotropin; aging; allergic rhinitis; angiogenesis; antineoplastic activity; apoptosis; autophagosome; bacterial infection; beverage; binding affinity; biocompatibility; breast cancer; cancer chemotherapy; cancer inhibition; cancer therapy; cantaloupe; CD8+ T lymphocyte; cell aggregation; cell cycle arrest; cell proliferation; cell survival; cell viability; Citrobacter rodentium; colorectal cancer; cytotoxicity; diabetes mellitus; DNA damage; DNA methylation; drug delivery system; drug release; encapsulation; erythrocyte aggregation; gene expression; genetic transfection; Helicobacter pylori; histopathology; human; IC50; immune response; liver cell carcinoma; MCF-7 cell line; melanoma; metastasis; MHCC97-H cell line; molecular interaction; nanomedicine; neuroendocrine tumor; non insulin dependent diabetes mellitus; ovary cancer; ovary polycystic disease; overall survival; pancreas cancer; photon correlation spectroscopy; photothermal therapy; progression free survival; prostate cancer; regulatory T lymphocyte; Review; rheumatoid arthritis; risk factor; signal transduction; stomach cancer; tumor growth; tumor volume; upregulation; uterine cervix cancer; virus infection; Zika fever
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue